Cancer has emerged as one of the leading public health challenges in India, with a rising disease burden and mortality.
ICMR–NCDIR data (2024): 15.6 lakh new cases and 8.74 lakh deaths.
Lifetime risk: 11% for Indians, highlighting an urgent need for prevention, awareness, and treatment infrastructure.
Key Findings from Cancer Registries
Gender Differences:
- Women: 51.1% of cases but only 45% of deaths (due to early detection of breast & cervical cancer).
- Men: Higher mortality as lung and gastric cancers dominate, often detected late with poor survival rates.
Rising Oral Cancer in Men:
- Oral cancer has surpassed lung cancer as the most common cancer among men.
- Reasons: long latency of tobacco effects, alcohol use, and combined tobacco–alcohol risks, despite declining tobacco prevalence.
Regional Disparities:
- Northeast most affected, especially Mizoram (21.1% men, 18.9% women lifetime risk).
- Causes: high tobacco use, unique food habits, infections (HPV, Helicobacter pylori).
Most Common Cancers:
- Women: Breast & cervical.
- Men: Oral, lung, gastric.
- Prostate cancer is emerging in ageing urban populations.
Significance of Findings
Need for region-specific policies, beyond generic national schemes.
Early detection, awareness, and lifestyle-based prevention are crucial.
Integration of cancer services into existing health schemes is essential.
India’s Multi-Pronged Strategy Against Cancer
National-Level Programmes:
- NPCDCS: Focuses on early detection (oral, breast, cervical).
- Strengthening Tertiary Care Scheme: Supports 19 State Institutes & 20 Centres.
- Ayushman Bharat (PM-JAY): Free cancer treatment for poor; 90% of registered patients covered.
- Health Minister’s Cancer Patient Fund: Up to ₹15 lakh per patient.
- National Cancer Grid: 287 centres with standardized protocols, treating 7.5 lakh new patients annually.
Budget & Infrastructure:
- Union Budget 2025–26: ₹1 lakh crore for healthcare, district-level day-care cancer centres.
- Customs duty exemptions on 36 life-saving cancer drugs.
Research & Innovation:
- NexCAR19 (2024): India’s first indigenous CAR-T therapy for blood cancers.
- Quad Cancer Moonshot (2024): Cervical cancer elimination drive (HPV vaccination & screening).
- ACTREC Expansion (2025): Strengthening cancer research & training.
Awareness & Lifestyle Interventions:
- Campaigns: Eat Right India, Fit India Movement, Yoga-based initiatives.
- National & global cancer awareness days used for public outreach.
Challenges in Tackling Cancer
Low registry coverage: Only 18% of population.
Late detection: Poor awareness and limited screening.
Healthcare inequality: Rural & Northeastern India underserved.
Socio-cultural barriers: Stigma, taboos, low literacy.
High financial burden: Diagnostics and medicines costly despite insurance schemes.
Way Forward
Expand Cancer Registries nationwide with digital health integration.
Strengthen Primary Healthcare with built-in cancer screening.
Universal HPV Vaccination for adolescent girls.
Targeted Awareness Campaigns on tobacco, alcohol, diet, and infections.
Affordable Treatment Expansion: More cancer centres, cheaper diagnostics.
Boost Research in low-cost diagnostics and personalized therapy.
Conclusion
India faces a dual challenge: increasing cancer burden and sharp regional disparities.
Policy responses are strong—NPCDCS, PM-JAY, NCG, CAR-T therapies, and vaccination drives.
With 30–50% of cancers preventable, focus must be on prevention, early detection, and equitable access.
Sustained efforts can transform cancer from a deadly health crisis into a manageable public health challenge.